Sign In
Buy ABBV
$224.93
+7.86 (+3.62%)
At Close: Jun 04, 2026
Can AbbVie Regain Its Status As a Top Dividend Growth Stock?
07:00am, Monday, 16'th Sep 2024
AbbVie's dividend growth has slowed, but new drugs are offsetting Humira's decline. The company's debt levels and payout ratio are high, but its shares screen as undervalued.
Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More
09:15am, Saturday, 14'th Sep 2024
Analyzing the board of directors is a quick way to assess people power. Scientific advisory boards are easier to analyze than they might seem.
3 Stocks to Buy and Hold Forever
07:30am, Saturday, 14'th Sep 2024
AbbVie has proved it can adapt to a fast-changing environment. Eli Lilly has a sustainable culture of growth.
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
05:51am, Saturday, 14'th Sep 2024
AbbVie is a Dividend King that's proven it can successfully navigate patent cliffs. Brookfield Infrastructure offers attractive distributions and has a solid long-term growth strategy.
AbbVie (ABBV) Is Considered a Good Investment by Brokers: Is That True?
10:36am, Friday, 13'th Sep 2024
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Pfizer Stock Vs. AbbVie
06:00am, Friday, 13'th Sep 2024
Given its better valuation, we believe that Pfizer stock (NYSE: PFE) is currently a better pick than its industry peer – AbbVie stock . PFE stock trades at a much lower multiple of 11x forward, vers
Is This Company Still a Strong Buy After Tripling the S&P 500's Returns?
05:15am, Friday, 13'th Sep 2024
AbbVie is a superbly managed organization. The company's leaders expertly positioned it for Humira's loss of patent protection.
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
10:05am, Thursday, 12'th Sep 2024
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Allergan Aesthetics Launches BOTOX® Cosmetic (onabotulinumtoxinA) for Masseter Muscle Prominence (MMP) in Adults in China
08:30am, Wednesday, 11'th Sep 2024
BOTOX® Cosmetic is the first neurotoxin approved in China for the treatment of masseter muscle prominence (MMP), the largest global market for MMP. Approval supported by well-established safety profi
UnitedHealth to remove AbbVie's Humira from some US drug reimbursement lists next year
12:28pm, Tuesday, 10'th Sep 2024
UnitedHealth Group said on Tuesday it will remove AbbVie's blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement as of Jan. 1, 2025, and recommend le
Dividend Income Summary: Lanny's August 2024 Summary
08:35am, Tuesday, 10'th Sep 2024
Investing in dividend stocks allows you to earn dividend income, the best passive income stream. In August, we (my wife and I) received a dividend income total of $1,415.47. 2023 was up 24%. Eight mon
Why AbbVie (ABBV) Outpaced the Stock Market Today
06:51pm, Monday, 09'th Sep 2024
AbbVie (ABBV) closed the most recent trading day at $196.42, moving +1.56% from the previous trading session.
3 Things You Need to Know if You Buy AbbVie Stock Today
12:05pm, Monday, 09'th Sep 2024
AbbVie's leadership and revenue mix have changed, and more change is coming. There's a good chance that it will diversify into a new pharmaceutical segment.
AbbVie Showcases Advancement of Solid Tumor Pipeline at ESMO 2024, with New Data in Tumor Types with High Unmet Needs
09:00am, Monday, 09'th Sep 2024
Full data from the primary analysis of the positive, single-arm Phase 2 PICCOLO trial, evaluating mirvetuximab soravtansine (ELAHERE®), for high folate receptor-alpha (FRα) expressing platinum-sensi
3 No-Brainer Dividend Stocks to Buy in September
07:30am, Sunday, 08'th Sep 2024
AbbVie is a Dividend King with solid growth prospects. Merck's looming patent cliff isn't as alarming as it might seem.
